Haloperidol-induced alteration in the physiological actions of group I mGlus in the subthalamic nucleus and the substantia nigra pars reticulata

Neuropharmacology

Volumn 43, Issue 2, 2002, Pages 147-159

  Marino, M J ^a   Awad Granko, H ^b   Ciombor, K J ^b   Conn, P J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Dopamine; Metabotropic glutamate receptor; Movement disorder; Substantia nigra pars reticulata; Subthalamic nucleus

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; HALOPERIDOL; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CALCIUM CELL LEVEL; CONTROLLED STUDY; DEPOLARIZATION; NONHUMAN; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; ANIMALS, NEWBORN; HALOPERIDOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0036669760     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00097-7     Document Type: Article

References (76)

1. Abarca J., Gysling K., Roth R., Bustos G. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: In vivo microdialysis studies. Neurochemistry Research. 20:1995;159-169.
2. Abbott A., Wigmore M.A., Lacey M.G. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor. Brain Research. 766:1997;162-167.
3. Alagarsamy S., Marino M.J., Rouse S.T., Gereau R.W., Heinemann S.F., Conn P.J. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nature Neuroscience. 2:1999;234-240.
4. Alagarsamy S., Sorensen S.D., Conn P.J. Coordinate regulation of metabotropic glutamate receptors. Current Opinions in Neurobiology. 11:2001;357-362.
5. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neuroscience. 12:1989;366-375.
6. Ango F., Pin J.P., Tu J.C., Xiao B., Worley P.F., Bockaert J., Fagni L. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. Journal of Neuroscience. 20:2000;8710-8716.
7. Awad H., Hubert G.W., Smith Y., Levey A.I., Conn P.J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. Journal of Neuroscience. 20:2000;7871-7879.
8. Aziz T.Z., Peggs D., Sambrook M.A., Crossman A.R. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Movement Disorders. 6:1991;288-292.
9. Benazzouz A., Piallat B., Pollak P., Limousin P., Gao D.M., Krack P., Benabid A.L. Single unit recordings of subthalamic nucleus and pars reticulata of substantia nigra in akineto-rigid parkinsonian patients. Society of Neuroscience Abstracts. 22:1996;91-118.
10. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1346-1348.
11. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus II. Neuronal activity in the MPTP model of parkinsonism. Journal of Neurophysics. 72:1994;507-520.
12. Betarbet R., Porter R.H.P., Greenamyre J.T. GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation. Journal of Neurochemistry. 74:2000;1166-1175.
13. Blandini F., Nappi G., Greenamyre J.T. Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease. Annals in Neurology. 49:2001;525-529.
14. Bradley S.R., Marino M.J., Wittmann M., Rouse S.T., Awad H., Levey A.I., Conn P.J. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra reticulata. Journal of Neuroscience. 20:2000;3085-3094.
15. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., Worley P.F. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature. 386:1997;284-288.
16. Calabresi P., Mercuri N.B., Bernardi G. Activation of quisqualate metabotropic glutamate receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum. Neuroscience Letters. 139:1992;41-44.
17. Calabresi P., Mercuri N., Sancessario G., Bernardi G. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain. 116:1993;433-452.
18. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. Journal of Neurochemistry. 75:2000;889-907.
19. Ciruela F., Solviev M.M., McIhinney R.A.J. Co-expression of metabotropic glutamate receptor type 1a with Homer 1a/Vesl-1S increases the cell surface expression of the receptor. Biochemical Journal. 341:1999;795-803.
20. Clark B.P., Baker S.R., Goldsworthy J., Harris J., Kingston A. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorganical Medicine and Chemistry Letters. 21:1997;2777-2780.
21. Colwell C.S., Levine M.S. Metabotropic glutamate receptors modulate N-methyl-D-aspartate receptor function in neostriatal neurons. Neuroscience. 61:1994;497-507.
22. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annual Reviews in Pharmacology and Toxicology. 37:1997;205-237.
23. Craven S.E., Bredt D.S. PDZ proteins organize synaptic signaling pathways. Cell. 93:1998;495-498.
24. Dale L.B., Bhattacharya M., Anborgh P.H., Murdoch B., Bhatia M., Nakanishi S., Ferguson S.S. G protein-coupled receptor kinase-mediated desensitization of metabotropic glutamate receptor 1A protects against cell death. Journal of Biological Chemistry. 275:2000;38213-38220.
25. De Blasi A., Conn P.J., Pin J., Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends in Pharmacological Science. 22:2001;114-120.
26. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends in Neuroscience. 13:1990;281-285.
27. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature. 394:1998;78-82.
28. 2+ pathway by phosphorylation of the receptor-G protein coupling domain. Proceedings of the National Academy of Science of the USA. 97:2000;6185-6190.
29. Gasparini F., Lingenhoel K., Flor P.J., Munier N., Heinrich M., Pagano A., Vranesic I., Biollaz M., Keckendom R., Allgeiger H., Varney M., Johnson E., Hess S.D., Velicelebi G., Kuhn R., Urban L. 2-methyl-6-(phenylethynyl)-pyridine (MPEP): a novel potent subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype. British Journal of Pharmacology. 125:1999;145P.
30. Gereau R.W., Heinemann S.F. Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor. Neuron. 20:(5):1998;143-151.
31. Hassani O.K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
32. Herrero I., Miras-Portugal M.T., Sanchez-Prieto J. Rapid desensitization of the metabotropic glutamate receptor that facilitates glutamate release in rat cerebrocortical nerve terminals. European Journal of Neuroscience. 6:1994;115-120.
33. Hirsch E.C., Perier C., Orieux G., Francois C., Feger J., Yelnik J., Vila M., Levy R., Tolosa E.S., Marin C., Trinidad Herrero M., Obeso J.A., Agid Y. Metabolic effects of nigrostriatal denervation in basal ganglia. Trends in Neuroscience. 23:2000;S78-S85.
34. Hollerman J.R., Grace A.A. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Research. 590:1992;291-299.
35. Hubert G.W., Paquet M., Smith Y. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. Journal of Neuroscience. 21:2001;1838-1847.
36. Kaatz K.W., Albin R.L. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study. Neuroscience. 66:1995;55-65.
37. Kammermeier P.J., Ikeda S.R. Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels. Neuron. 22:1999;819-829.
38. Kammermeier P.J., Xiao B., Tu J.C., Worley P.F., Ikeda S.R. Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. Journal of Neuroscience. 20:2000;7238-7245.
39. Kato A., Ozawa F., Saitoh Y., Hirai K., Inokuchi K. Vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Letters. 412:1997;183-189.
40. Kornau H.C., Seeburg P.H., Kennedy M.B. Interaction of ion channels and receptors with PD2 domain proteins. Current Opinion in Neurobiology. 7:1997;368-373.
41. Limousin P., Pollak P., Benazzouz A., Hoffman D., Broussolle E., Perret J.E., Benabid A.L. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Movement Disorders. 10:1995;672-674.
42. Limousin P., Pollak P., Benazzouz A., Hoffman D., Le Bas J.F., Broussolle E., Perret J.E., Benabid A.L. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
43. Lovinger D.M., McCool B.A. Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGluR2 or 3. Journal of Neurophysicsiol. 73:1995;1076-1083.
44. Luthi A., Gahwiler B.H., Gerber U. Potentiation of a metabotropic glutamatergic response following NMDA receptor activation in rat hippocampus. Pflugers Archives-European Journal of Physics. 427:1994;197-202.
45. Macek T.A., Schaffhauser H., Conn P.J. Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. Journal of Neuroscience. 18:1998;6138-6146.
46. Magill P.J., Bolam J.P., Bevan M.D. Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. Journal of Neuroscience. 20:2000;820-833.
47. Magill P.J., Bolam J.P., Bevan M.D. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience. 106:2001;313-330.
48. Maltseva O., Conn P.J. Functional roles of group I metabotropic glutamate receptors in two neuronal populations in rat globus pallidus. Society of Neuroscience Abstracts. 26:2000;740.
49. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. Journal of Neuroscience. 21:2001;5925-5934.
50. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. Journal of Neuroscience. 21:2001;7001-7012.
51. Meltzer L.T., Serpa K.A., Christofferesen C.L. Metabotropic glutamate receptor mediated inhibition and excitation of substantia nigra dopamine neurons. Synapse. 26:1997;184-193.
52. Mercuri N.B., Stratta F., Calabresi P., Bonci A., Bernardi G. Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons. Neuroscience. 56:1993;399-407.
53. Miller W.C., DeLong M.R. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. Carpenter M.B., Jayaraman A., The basal ganglia II. 1987;415-427 Plenum, New York.
54. Ossowska K., Konieczny J., Wolfarth S., Wieronska J., Pilc A. Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology. 41:2001;413-420.
55. Pisani A., Calabresi P., Centonze D., Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. British Journal of Pharmacology. 120:1997;1007-1014.
56. Poisik O., Conn P.J. Postsynaptic roles of metabotropic glutamate receptors in rat globus pallidus. IBAGS Abstracts. 28:2001.
57. Porter R., Greene J., Higgins D., Greenamyre J.T. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activity in the basal ganglia of rats with unilateral dopamine depletion. Journal of Neuroscience. 14:1994;7192-7199.
58. Richards C.D., Shiroyama T., Kitai S.T. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat. Neuroscience. 80:1997;545-557.
59. Rodriguez-Puertas R., Herrera-Marschitz M., Koistinaho J., Hokfelt T. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine lesioned rats. Neuroscience. 89:1999;781-797.
60. Sallese M., Salvatore L., D'Urbano E., Sala G., Storto M., Launey T., Nicoletti F., Knopfel T., De Blasi A. The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor. FASEB. 14:2000;2569-2580.
61. Saugstad J.A., Marino M.J., Folk J.A., Hepler J.R., Conn P.J. RGS4 inhibits signaling by group I metabotropic glutamate receptors. Journal of Neuroscience. 18:1998;905-913.
62. Schoepp D.D., Johnson B.G. Selective inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in the rat hippocampus by activation of protein kinase C. Biochemical Pharmacology. 37:1988;4299-4305.
63. Shen K.Z., Johnson S.W. A slow excitatory postsynaptic current mediated by G-protein coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. European Journal of Neuroscience. 9:1997;48-54.
64. Sheng M. PDZs and receptor/channel clustering: rounding up the latest suspects. Neuron. 17:1996;575-578.
65. Singha S.R., Saggau P. Simultaneous optical recording of membrane potential and intracellular calcium from brain slices. Methods. 18:1999;204-214.
66. Spooren W.P., Gasparini F., Bergmann R., Kuhn R. Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. European Journal of Pharmacology. 406:2000;403-410.
67. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. Journal of Neuroscience. 14:1994;3005-3018.
68. Tu J.C., Xiao B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., Linden D.J., Worley P.F. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron. 21:1998;717-726.
69. Wichmann T., DeLong M.R. Physiology of the basal ganglia and pathophysiology of movement disorders of basal ganglia origin. Watts R.L., Movement disorders: neurological principles and practice. 1997;87-97 McGraw-Hill, New York.
70. Wigmore M.A., Lacey M.G. Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurons in vitro. British Journal of Pharmacology. 123:1998;667-674.
71. Wittmann M., Marino M.J., Bradley S.R., Conn P.J. Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata. Journal of Neurophysics. 85:2001;1960-1968.
72. Wittmann M., Hubert G.W., Smith Y., Conn P.J. Activation of metabotropic glutamate receptor 1 inhibits glutamatergic transmission in the substantia nigra pars reticulata. Neuroscience. 105:2001;881-889.
73. Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D., Ruggiero A., Lanahan A.A., Wenthold R.J., Worley P.F. Homer regulates the association of group I metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins. Neuron. 21:1998;707-716.
74. Yamamoto B., Cooperman M. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. Journal of Neuroscience. 14:1994;4159-4166.
75. Yu T.S., Wang S.D., Liu J.C., Yin H.S. Changes in gene expression of GABAA receptor α1 and α2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts. Experimental Neurology. 168:2001;231-241.
76. Ziff E.B. Enlightening the postsynaptic density. Neuron. 19:1997;1163-1174.